HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Shinozaki Selected Research

K Shinozaki Research Topics

Disease

10Dehydration (Water Stress)
06/2001 - 03/2000
7Neoplasms (Cancer)
06/2018 - 05/2000
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 05/2015
3Infections
12/2001 - 03/2001
2Colonic Neoplasms (Colon Cancer)
11/2021 - 01/2016
2Drug-Related Side Effects and Adverse Reactions
10/2001 - 03/2001
1Opioid-Induced Constipation
06/2018
1Adenocarcinoma
10/2015
1Stomach Neoplasms (Stomach Cancer)
10/2015
1Neutropenia
05/2015
1Onychomycosis (Tinea Unguium)
04/2014
1Colitis
11/2009
1Pseudomembranous Enterocolitis (Pseudomembranous Colitis)
11/2009
1Pancreatitis
11/2009
1Renal Insufficiency (Renal Failure)
11/2009
1Acute Kidney Injury (Acute Renal Failure)
11/2009
1Carcinoma (Carcinomatosis)
09/2003
1Gastroenteritis
07/2002
1Serous Cystadenoma
01/2002
1Chronic Pancreatitis
01/2002
1Bruton type agammaglobulinemia
12/2001
1Nephrotic Syndrome (Syndrome, Nephrotic)
09/2001
1Convalescence
08/2001
1Necrosis
06/2001
1Esophageal Neoplasms (Esophageal Cancer)
04/2001
1Shock
02/2001
1Pathologic Constriction (Stenosis)
01/2001
1Insulin Resistance
09/2000
1Neuroblastoma
03/2000

Drug/Important Bio-Agent (IBA)

5ElementsIBA
02/2001 - 03/2000
4Abscisic AcidIBA
10/2000 - 06/2000
3Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2021 - 01/2016
3Carrier Proteins (Binding Protein)IBA
07/2000 - 03/2000
2Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 05/2015
2MucinsIBA
01/2002 - 05/2000
1Cetuximab (Erbitux)FDA Link
01/2019
1regorafenibIBA
01/2019
1Narcotic Antagonists (Opioid Antagonists)IBA
06/2018
1naldemedineIBA
06/2018
1Bevacizumab (Avastin)FDA Link
01/2016
1S-1 plus cisplatinIBA
10/2015
1Hydrocortisone (Cortisol)FDA LinkGeneric
04/2014
1Itraconazole (Sporanox)FDA LinkGeneric
04/2014
1Cytochrome P-450 CYP3AIBA
04/2014
1Cytochrome P-450 CYP3A InhibitorsIBA
04/2014
1VancomycinFDA LinkGeneric
11/2009
1Telomerase (Telomerase Reverse Transcriptase)IBA
08/2003
1Antineoplastic Agents (Antineoplastics)IBA
08/2003
1Capsid Proteins (Capsid Protein)IBA
07/2002
1Immunoglobulin G (IgG)IBA
12/2001
1Agammaglobulinaemia Tyrosine KinaseIBA
12/2001
1SteroidsIBA
09/2001
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2001
1Signaling Lymphocytic Activation Molecule Associated ProteinIBA
08/2001
1DNA (Deoxyribonucleic Acid)IBA
08/2001
1Immunoglobulins (Immunoglobulin)IBA
06/2001
1Phosphatidic Acids (Phosphatidic Acid)IBA
06/2001
1Phospholipase DIBA
06/2001
1Messenger RNA (mRNA)IBA
06/2001
1Type C PhospholipasesIBA
02/2001
1Inositol 1,4,5-TrisphosphateIBA
02/2001
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2001
11- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA
02/2001
1EnzymesIBA
02/2001
1NeomycinFDA LinkGeneric
02/2001
1Mannitol (Osmitrol)FDA LinkGeneric
02/2001
1Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)IBA
02/2001
1SecretinFDA Link
01/2001
1FructoseIBA
09/2000
1Triglycerides (Triacylglycerol)IBA
09/2000
1Complementary DNA (cDNA)IBA
06/2000
19-cis-epoxy-carotenoid dioxygenaseIBA
06/2000
1DNA-Binding Proteins (DNA Binding Protein)IBA
06/2000
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2000
1GlucuronidaseIBA
03/2000

Therapy/Procedure

4Therapeutics
05/2015 - 09/2001
2Catheters
10/2001 - 03/2001
1Adjuvant Chemotherapy
11/2021
1Drug Therapy (Chemotherapy)
10/2015
1Oral Administration
11/2009
1Hemodiafiltration
11/2009
1Vascular Access Devices (Arterial Line)
10/2001
1Fluid Therapy (Oral Rehydration Therapy)
06/2001
1Esophagectomy
04/2001